web analytics
Home  »  Archives

PharmaWatch

Page 1 of 212

Lorcaserin or Lorqess: Analysis of FDA Panel

Written on 6 Sep, 2010 at 7:09 in PharmaWatch | viewed 531 views times | 4 Comments
Lorcaserin or Lorqess: Analysis of FDA Panel

This is an analysis of Lorcaserin or Lorqess and the upcoming FDA advisory panel.  If curious or have any questions or want more such analysis, please email dg_writing@hotmail.com – thanks! Lorcaserin or Lorqess is going up for an FDA advisory... (Continue reading)

Analysis: Probability of Acthar Approval

Written on 11 Jun, 2010 at 14:03 in PharmaWatch | viewed 588 views times | 1 Comment
Analysis: Probability of Acthar Approval

This is selected excerpts from an analysis Health and Life published for the pharmaceutical industry.  If interested in receiving similar reports for future drug approvals, email dg_writing@hotmail.com  Thank you. Who: Questcor (QCOR: $10.02) is a small pharmaceutical company seeking an... (Continue reading)

Obesity Drugs 2010, Which Is the Best?

Written on 18 May, 2010 at 7:54 in PharmaWatch | viewed 2,299 views times | 6 Comments
Obesity Drugs 2010, Which Is the Best?

Three weight-loss pills are going up for FDA approval this year, 2010 – Qnexa, lorcaserin, and Contrave.  Here we present the state of the field for weight-loss pills and analyze each treatment. Currently, there are not that many treatments for... (Continue reading)

Tagged with:         

Vyvanse: Many Advantages as ADHD Therapy?

Written on 7 May, 2010 at 12:35 in PharmaWatch | viewed 28,884 views times | 20 Comments
Vyvanse: Many Advantages as ADHD Therapy?

Vyvanse is a new treatment for ADHD that is very promising.  Importantly, it has several advantages that distinguish it from the many competing treatments.  At Health and Life, we are skeptical by nature, but there are advantages to Vyvanse that... (Continue reading)

Tagged with:

The New Medications in 2010 – Highlights

Written on 22 Apr, 2010 at 12:00 in PharmaWatch | viewed 565 views times | 1 Comment
The New Medications in 2010 - Highlights

As someone who spends a fair bit of time thinking about and dealing with medications and treatments, I like to think I know a little about the subject.  And, to be honest, I was getting a little concerned.  It seemed... (Continue reading)

Qnexa for Weight Loss; Side Effects

Written on 16 Apr, 2010 at 6:23 in New Drugs, PharmaWatch | viewed 1,984 views times | 2 Comments
Qnexa for Weight Loss; Side Effects

Qnexa is a new medication that will go for FDA approval in 2010 and is a treatment for obesity.  It consists of phentermine and topiramate and has shown excellent results in studies to date.  Concerns, however, remain about its safety... (Continue reading)

Tagged with:     

The Weekly Pharma News Update #6

Written on 28 Mar, 2010 at 8:57 in PharmaWatch | viewed 27 views times | No Comments
The Weekly Pharma News Update #6

It’s Sunday – and that means another Weekly Pharma News Update from Health and Life.  What were the most interesting and important news items of the last week regarding the biopharmaceutical industry? #1 Nobel Prize-winning scientist Sir James Black dies... (Continue reading)

The Weekly Pharma News Update #5

Written on 21 Mar, 2010 at 12:01 in PharmaWatch | viewed 29 views times | No Comments
The Weekly Pharma News Update #5

Another Sunday, another Pharma news update from Health and Life.  What were the biggest news items of the last week and what might they mean? #1 Diabetes Heart Treatments May Cause Harm Recent data indicates that aggressive control of diabetic... (Continue reading)

The Very Best Pharma Blogs & Resources

Written on 14 Mar, 2010 at 9:30 in PharmaWatch | viewed 2,335 views times | 8 Comments
The Very Best Pharma Blogs & Resources

There is a lot going on in the world of Pharmaceuticals.  Drugs are being discovered, being marketed, and, far too often it seems, being recalled. How much will a new medication sell?  Will it make through the clinical trials without... (Continue reading)

The Weekly Pharma News Update #4

Written on 14 Mar, 2010 at 7:04 in PharmaWatch | viewed 31 views times | No Comments
The Weekly Pharma News Update #4

Another Sunday, another Pharma News Update, where we summarize the most important and interesting Bio-Pharmaceutical news from the last week. Last week was ominously grim.  Many drugs failed to show efficacy.  The bisphosphonate meds like Fosamax and Boniva might increase... (Continue reading)

Page 1 of 212